(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.08%) $82.56
(1.13%) $2.05
(-0.50%) $2 345.80
(-0.98%) $27.39
(-0.02%) $961.30
(0.08%) $0.933
(0.18%) $11.00
(0.04%) $0.796
(0.01%) $93.31
Live Chart Being Loaded With Signals
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes...
Stats | |
---|---|
今日成交量 | 35 959.00 |
平均成交量 | 10 800.00 |
市值 | 3.32M |
EPS | $0 ( 2024-02-08 ) |
下一个收益日期 | ( $-4.60 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.350 |
ATR14 | $0.0670 (1.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-23 | Jantzen Beth | Buy | 98 039 | Incentive Stock Option (right to buy) |
2023-03-23 | Jantzen Beth | Buy | 91 667 | Common Stock |
2023-03-23 | Jantzen Beth | Buy | 1 961 | Non-Qualified Stock Option (right to buy) |
2023-03-23 | Shorrock Clay | Buy | 98 039 | Incentive Stock Option (right to buy) |
2023-03-23 | Shorrock Clay | Buy | 91 667 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 2 995 668 | Sell: 475 226 |
音量 相关性
Applied DNA Sciences Inc 相关性 - 货币/商品
Applied DNA Sciences Inc 财务报表
Annual | 2023 |
营收: | $13.37M |
毛利润: | $5.53M (41.39 %) |
EPS: | $-0.760 |
FY | 2023 |
营收: | $13.37M |
毛利润: | $5.53M (41.39 %) |
EPS: | $-0.760 |
FY | 2022 |
营收: | $18.17M |
毛利润: | $5.05M (27.82 %) |
EPS: | $-0.930 |
FY | 2021 |
营收: | $9.03M |
毛利润: | $4.93M (54.59 %) |
EPS: | $-2.07 |
Financial Reports:
No articles found.
Applied DNA Sciences Inc
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。